| Literature DB >> 18560474 |
Cui-Qin Huang1, Robin B Gasser, Cinzia Cantacessi, Alasdair J Nisbet, Weiwei Zhong, Paul W Sternberg, Alex Loukas, Jason Mulvenna, Rui-Qing Lin, Ning Chen, Xing-Quan Zhu.
Abstract
Differential transcription in Ascaris suum was investigated using a genomic-bioinformatic approach. A cDNA archive enriched for molecules in the infective third-stage larva (L3) of A. suum was constructed by suppressive-subtractive hybridization (SSH), and a subset of cDNAs from 3075 clones subjected to microarray analysis using cDNA probes derived from RNA from different developmental stages of A. suum. The cDNAs (n = 498) shown by microarray analysis to be enriched in the L3 were sequenced and subjected to bioinformatic analyses using a semi-automated pipeline (ESTExplorer). Using gene ontology (GO), 235 of these molecules were assigned to 'biological process' (n = 68), 'cellular component' (n = 50), or 'molecular function' (n = 117). Of the 91 clusters assembled, 56 molecules (61.5%) had homologues/orthologues in the free-living nematodes Caenorhabditis elegans and C. briggsae and/or other organisms, whereas 35 (38.5%) had no significant similarity to any sequences available in current gene databases. Transcripts encoding protein kinases, protein phosphatases (and their precursors), and enolases were abundantly represented in the L3 of A. suum, as were molecules involved in cellular processes, such as ubiquitination and proteasome function, gene transcription, protein-protein interactions, and function. In silico analyses inferred the C. elegans orthologues/homologues (n = 50) to be involved in apoptosis and insulin signaling (2%), ATP synthesis (2%), carbon metabolism (6%), fatty acid biosynthesis (2%), gap junction (2%), glucose metabolism (6%), or porphyrin metabolism (2%), although 34 (68%) of them could not be mapped to a specific metabolic pathway. Small numbers of these 50 molecules were predicted to be secreted (10%), anchored (2%), and/or transmembrane (12%) proteins. Functionally, 17 (34%) of them were predicted to be associated with (non-wild-type) RNAi phenotypes in C. elegans, the majority being embryonic lethality (Emb) (13 types; 58.8%), larval arrest (Lva) (23.5%) and larval lethality (Lvl) (47%). A genetic interaction network was predicted for these 17 C. elegans orthologues, revealing highly significant interactions for nine molecules associated with embryonic and larval development (66.9%), information storage and processing (5.1%), cellular processing and signaling (15.2%), metabolism (6.1%), and unknown function (6.7%). The potential roles of these molecules in development are discussed in relation to the known roles of their homologues/orthologues in C. elegans and some other nematodes. The results of the present study provide a basis for future functional genomic studies to elucidate molecular aspects governing larval developmental processes in A. suum and/or the transition to parasitism.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18560474 PMCID: PMC2398786 DOI: 10.1371/journal.pntd.0000246
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Analysis using the Basic Local Alignment Search Tool (BLAST).
| Classification of molecules based on similarity (BLASTx) to molecules in | Numbers |
|
| 16 (6) |
|
| 2 |
| Exclusively other ascaridoid nematodes | 1 |
|
| 16 (3) |
|
| 27 (9) |
| Exclusively other organisms | 5 |
| No known homologue in any organisms | 35 |
| Totals | 91 |
Summary of results from bioinformatic and microarray analyses of expressed sequence tags (ESTs) with significant differential transcription between infective third-stage larva (L3) of Ascaris suum and other developmental stages.
Numbers in brackets refer to C. elegans homologues with known non-wildtype RNAi phenotypes (see Table 2).
Caenorhabditis elegans orthologues.
| EST code | Size (bp) |
| Description of | RNAi phenotype | Other ascaridoid nematodes [non-ascaridoid nematodes] |
| Apoptosis; Insulin signalling pathway | |||||
| 22H01 | 698 | Q/0/Cy | Predicted regulatory subunit of a cAMP-dependent protein kinase ( | Lva, Lvl, Bmd, Dpy, Unc, Stp |
|
| ATP synthesis | |||||
| 28A02 | 686 | Q/0/Mi | Mitochondrial F1F0-ATP synthase ( | Emb1,2, Ste, Age, Gro |
|
| Carbon fixation; Citrate cycle (TCA cycle); Pyruvate metabolism; Reductive carboxylate cycle (CO2 fixation) | |||||
| 11C02 | 403 | Q/0/Cy | Malate dehydrogenase (F46E10.10) |
| |
| Fatty acid biosynthesis | |||||
| 30A01 | 553 | Q/0/Cy | Short-chain dehydrogenase ( |
| |
| Gap junction | |||||
| 13E09 | 541 | Q/0/Cy_Nu | alpha-tubulin ( | Emb1,3, Gro, Lva, Lvl |
|
| Glycolisis/Gluconeogenesis; Phenylalanine, tyrosine and tryptophan biosynthesis | |||||
| 22H06 | 460 | Q/0/Cy | Enolase (T21B10.2, | Emb1, Lva, Gro, Clr |
|
| 15G04 | 641 | Q/0/Mi | Enolase (T21B10.2, | Emb1, Lva, Gro, Clr |
|
| Glyoxylate and decarboxylate metabolism | |||||
| 11C02 | 403 | Q/0/Cy | Malate dehydrogenase (F46E10.10) |
| |
| 29E06 | 469 | Q/0/Cy_Nu | Predicted hydrolase, HAD superfamily (F45E1.3) |
| |
| Huntington's disease | |||||
| 18C04 | 829 | Q/0/Cy_Nu | Proposed component of the intraflagellar transport (IFT) complex B ( | ||
| Porphyrin metabolism | |||||
| 2G04 | 505 | Q/0/Pl | Heavy chain ferritin ( |
| |
| Starch and sucrose metabolism | |||||
| 18D07 | 441 | S/0/Ex | Putative trehalase ( |
| |
| Other enzymes | |||||
| 03C04 | 520 | Q/0/Cy | Peptidylglycine alpha-amidating monooxygenase (Y71G12B.4) | Age |
|
| 21G04 | 238 | S/0/Ex | Peptidylglycine alpha-amidating monooxygenase (Y71G12B.4) | Age |
|
| Unassigned pathway | |||||
| 01G03 | 544 | Q/0/Nu | Troponin ( | Gro, Slu, Unc, Stp, Ste |
|
| 04G09 | 542 | Q/0/Cy_Nu | Immunoglobin and related proteins (KOG4475, |
| |
| 07E12 | 519 | S/0/Ex | Unnamed protein ( |
| |
| 09A01 | 639 | Q/0/Cy_Nu | Subtilisin-like proprotein convertase ( | Ric, Age |
|
| 09G10 | 741 | Q/0/Cy | Polyadenylate- binding protein ( | Gro, Stp, transposon silencing abnormal, reproductive system morphology abnormal, Fgc, Pvl, Rup, Bmd, Ste, Emb1,4 |
|
| 10E04 | 489 | Q/0/Ex | Defense-related protein containing SCP domain ( |
| |
| 13C11 | 551 | A/0/Mi | G protein signaling regulators ( |
| |
| 13E04 | 472 | Q/0/Cy | Unnamed protein (B0546.2) | ||
| 18B10 | 566 | Q/1/Ex | Cell differentiation regulator of the Headcase family ( |
| |
| 18E12 | 673 | Q/0/Cy | Phosphoenolpyruvate carboxykinase (W05G11.6) |
| |
| 20D08 | 506 | Q/0/Nu | Protein tyrosine phosphatase ( |
| |
| 22C06 | 366 | Q/0/Ex | Unnamed protein ( |
| |
| 24H07 | 714 | Q/1/Pl | Neural proliferation, differentiation and control protein ( | Ric |
|
| 29F02 | 471 | S/0/Pl | Unnamed protein (H05L03.3) | Fat content increased |
|
| 30A01 | 653 | Q/0/Cy | Mitochondrial/plastidial beta-ketoacyl-ACP reductase ( |
| |
| 30C11 | 508 | Q/0/Cy | Calmodulin and related proteins (EF-Hand superfamily) ( |
| |
| 2G12 | 653 | Q/0/Ex | Alpha crystallins ( |
| |
| 4F10 | 513 | Q/0/Cy | Predicted ATP-dependent RNA heclicase FAL1 ( | Lva, Emb1,5,6,7,8,9,10,11,12, early larval arrest, Mul |
|
| 4G11 | 536 | Q/0/Cy | Predicted P-loop ATPase fused to an acetyltransferase (F55A12.8) | Gro, Unc, Pvl, Emb1, Lva, Ste, early larval arrest |
|
| 6E01 | 472 | S/0/Ex | Unnamed protein ( | Sck, Ste, Pvl, transgene subcellular localization abnormal, Emb1, Lva | |
| 10D07 | 639 | S/0/Nu | Predicted membrane protein, contains two CBS domains ( | ||
| 11F10 | 566 | Q/1/Cy | Cell differentiation regulator of the Headcase family (K07A1.7) |
| |
| 12C05 | 547 | Q/0/Cy | Actin regulatory proteins (gelsolin/villin family) (K06A4.3) |
| |
| 13B06 | 458 | Q/1/Pl | Unnamed protein (C44C10.9) | ||
| 14B05 | 259 | Q/0/Mi | Uncharacterized conserved protein (F09G8.5) | ||
| 18A11 | 575 | Q/0/Mi | Uncharacterized conserved protein (C16C10.11) |
| |
| 18B04 | 393 | Q/0/Ex | Alpha crystallins ( |
| |
| 18D12 | 740 | Q/2/Pl | Uncharacterized protein, contains CX module (H06I04.6) |
| |
| 24D03 | 804 | Q/0/Ex | Defense-related protein containing SCP domain ( |
| |
| 24F05 | 412 | S/1/Ex | Unnamed protein ( | Emb1 | |
| 26A11 | 647 | Q/0/Nu | Unnamed protein ( |
| |
| 26G12 | 532 | Q/0/Cy | 60S ribosomal protein L22 ( | Emb1,13, , Lva, Ste, Lon, Gro, Pch |
|
| 28A09 | 455 | Q/0/Cy | Phosphoenolpyruvate carboxykinase (W05G11.6) |
| |
| 30D01 | 255 | Q/0/Cy | Unnamed protein (F09E10.7) |
| |
Ascaris suum expressed sequence tags (ESTs) (listed according to KOBAS classification) with homologues in C. elegans and other nematodes (BLASTn analysis) and with a significantly higher (>2.0-fold) transcription in the infective third-stage larva (L3) compared with other stages. C. elegans homologues with known RNAi phenotypes have been also included.
*: Abbreviations used in proteomic analysis: Non-secretory protein (Q), signal anchor (A), secretory protein (S)/ predicted number of transmembrane domains/ predominat cellular location: cytoplasm (Cy); extracellular (Ex); mitochondrial (Mi), nuclear (Nu), plasma membrane (Pl).
**: Abbreviations of RNAi phenotypes (alphabetical): lifespan abnormal (Age), body morphology defect (Bmd), clear (Clr), dumpy (Dpy), embryonic lethal (Emb1), general pace of development abnormal early emb (Emb2), mitotic spindle abnormal early emb (Emb3), embryo osmotic integrity abnormal early emb (Emb4), excessive blebbing early emb (Emb5), large cytoplasmic granules early emb (Emb6), cell cycle slow early emb (Emb7), ectopic cleavage furrows early emb (Emb8), nuclear reassembly abnormal early emb (Emb9), polar body abnormal early emb (Emb10), pronuclear size abnormal early emb (Emb11), excess maternal pronucleus early emb (Emb12), chromosome segregation abnormal karyomeres early emb (Emb13), fewer germ cells (Fgc), slow growth (Gro), larval lethal (Let), long body (Lon), larval arrest (Lva), early larva lethal (Lvl), multiple nuclei early emb (Mul), patchy coloration (Pch), protruding vulva (Pvl), aldicarb resistant (Ric), ruptured (Rup), sick (Sck), sluggish (Slu), sterile (Ste), sterile progeny (Stp), uncoordinated (Unc).
***: Abbreviations of nematode species (alphabetical): Ancylostoma caninum (Aca), Ancylostoma ceylanicum (Ace), Ascaris lumbricoides (Alu), Anisakis simplex (Asi), Brugia malayi (Bma), Caenorhabditis briggsae (Cbr), Dirofilaria immitis (Dim), Globodera pallida (Gpa), Globodera rostochiensis (Gro), Haemonchus contortus (Hco), Heterodera glycines (Hgl), Heterodera schachtii (Hsc), Litomosoides sigmodontis (Lsi), Meloidogyne arenaria (Mar), Meloidogyne chitwoodi (Mch), Meloidogyne hapla (Mha), Meloidogyne javanica (Mja), Meloidogyne incognita (Min), Meloidogyne paranaensis (Mpa), Necator americanus (Nam), Nippostrongylus brasiliensis (Nbr), Ostertagia ostertagi (Oos), Onchocerca volvulus (Ovo), Parascaris univalens (Pun), Parastrongyloides trichosuri (Ptr), Parelaphostrongylus tenuis (Pte), Pristionchus pacificus (Ppa), Pratylenchus penetrans (Ppe), Pratylenchus vulnus (Pvu), Strongyloides ratti (Sra), Strongyloides stercoralis (Sst), Toxocara canis (Tca), Teladorsagia circumcincta (Tci), Trichuris muris (Tmu), Trichinella spiralis (Tsp), Trichostrongylus vitrinus (Tvi), Wuchereria bancrofti (Wbr), Xiphinema index (Xin), Zeldia punctata (Zpu).
Figure 1Gene ontologies.
Summary of predicted functions and locations for gene products inferred from 32 clusters of molecules enriched in the infective third-stage larva (L3) of Ascaris suum, classified according to the gene ontology (GO) categories ‘cellular component’ ‘biological process’ and ‘molecular function’ as well as subcategories within.
Figure 2Probablistic gene interaction networking.
The genetic interactions were predicted for a subset of nine C. elegans genes [kin-2, pab-1, T12B10.2, mec-12, rpl-22, mup-2, F33D11.10 ( = enol-1), egl-3 and F55A12.8; in red] with homologues/orthologues in Ascaris suum which displayed significantly increased transcription in the infective third-stage larva (L3) compared with other developmental stages. Interactors are indicated in black.